High materiality7/10
Ultragenyx (RARE) PT Lowered to $18 at Wells Fargo, Downgrades to Equalweight
Why it may matterVerify against the original reporting
bearish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Wells Fargo lowers RARE price target to $18; downgrade.
- Wells Fargo lowers RARE price target to $18; downgrade.
Key facts
- 01
Target: $18
- 02
Posted price: $26.53
- 03
Analyst firm: Wells Fargo
- 04
Analyst: Ben Burnett
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.